{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:41:12Z","timestamp":1787164872551,"version":"build-2736575974"},"reference-count":78,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Nature Science Foundation of China","award":["32000884"],"award-info":[{"award-number":["32000884"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Transthyretin amyloidosis (ATTR) is a progressive and systemic disease caused by the misfolding and amyloid aggregation of transthyretin (TTR). Stabilizing the TTR tetramers and disrupting the formed TTR aggregation are treated as a promising strategy for the treatment of ATTR. Previous studies have reported that epigallocatechin gallate (EGCG) can participate in the whole process of TTR aggregation to prevent ATTR. However, the interaction mechanism of EGCG in this process is still obscure. In this work, we performed molecular dynamics simulations to investigate the interactions between EGCG and TTR tetramers, and between EGCG and TTR aggregates formed by the V30M mutation. The obtained results suggest that EGCG at the binding site of the V30M TTR tetramer can form stable hydrogen bonds with residues in the flexible AB-loop and EF-helix-loop, which reduces the structural mobility of these regions significantly. Additionally, the polyaromatic property of EGCG contributes to the increasement of hydrophobicity at the binding site and thus makes the tetramer difficult to be solvated and dissociated. For V30M-TTR-generated aggregates, EGCG can promote the dissociation of boundary \u03b2-strands by destroying key residue interactions of TTR aggregates. Moreover, EGCG is capable of inserting into the side-chain of residues of neighboring \u03b2-strands and disrupting the highly structured aggregates. Taken together, this study elucidates the role of EGCG in preventing TTR amyloidosis, which can provide important theoretical support for the future of drug design for ATTR.<\/jats:p>","DOI":"10.3390\/ijms241814146","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:12:21Z","timestamp":1694931141000},"page":"14146","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates"],"prefix":"10.3390","volume":"24","author":[{"given":"Huizhen","family":"Zou","sequence":"first","affiliation":[{"name":"Chongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications, Chongqing 400065, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-2925","authenticated-orcid":false,"given":"Shuangyan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory of Big Data for Bio Intelligence, Chongqing University of Posts and Telecommunications, Chongqing 400065, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.18388\/abp.1997_4400","article-title":"Crystal structure of rat transthyretin at 2.5 \u00c5 resolution: First report on a unique tetrameric structure","volume":"44","author":"Wojtczak","year":"1997","journal-title":"Acta Biochim. Pol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0009-8981(68)90173-3","article-title":"Influence of age and sex on prealbumin levels","volume":"20","author":"Stabilini","year":"1968","journal-title":"Clin. Chim. Acta"},{"key":"ref_3","first-page":"338","article-title":"Thyroxine transport from blood to brain via transthyretin synthesis in choroid plexus","volume":"258","author":"Schreiber","year":"1990","journal-title":"Am. J. Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1515\/CCLM.2002.223","article-title":"Transthyretin as a thyroid hormone carrier: Function revisited","volume":"40","author":"Palha","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1073\/pnas.82.8.2488","article-title":"Plasma and cellular retinoid-binding proteins and transthyretin (prealbumin) are all localized in the islets of Langerhans in the rat","volume":"82","author":"Kato","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","first-page":"23","article-title":"Expression of transthyretin and retinol binding protein mRNAs and secretion of transthyretin by cultured monkey retinal pigment epithelium","volume":"10","author":"Pfeffer","year":"2004","journal-title":"Mol. Vis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0022-2836(71)90218-X","article-title":"An X-ray study of the subunit structure of prealbumin","volume":"61","author":"Blake","year":"1971","journal-title":"J. Mol. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0022-2836(78)90368-6","article-title":"Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A","volume":"121","author":"Blake","year":"1978","journal-title":"J. Mol. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1107\/S0907444996003046","article-title":"Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3\u2019,5\u2019-dinitro-N-acetyl-L-thyronine at 2.2 A resolution","volume":"52","author":"Wojtczak","year":"1996","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmb.2011.12.060","article-title":"The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug","volume":"421","author":"Johnson","year":"2012","journal-title":"J. Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: Chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/bi00542a009","article-title":"Binding of thyroid hormones and analogues to the human plasma protein prealbumin","volume":"19","author":"Andrea","year":"1980","journal-title":"Biochemistry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00415-017-8708-4","article-title":"Transthyretin familial amyloid polyneuropathy: An update","volume":"265","year":"2018","journal-title":"J. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1177\/10600280211000351","article-title":"Transthyretin Amyloid Cardiomyopathy\u2014Current and Future Therapies","volume":"55","author":"Yadav","year":"2021","journal-title":"Ann. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"105313","DOI":"10.1016\/j.neuint.2022.105313","article-title":"Transthyretin: Its function and amyloid formation","volume":"155","author":"Ueda","year":"2022","journal-title":"Neurochem. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","article-title":"Liver transplantation for hereditary transthyretin amyloidosis: After 20 years still the best therapeutic alternative?","volume":"99","author":"Ericzon","year":"2015","journal-title":"Transplantation"},{"key":"ref_18","first-page":"E6741","article-title":"Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition","volume":"115","author":"Lorena","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1517\/14656566.2016.1145664","article-title":"TTR kinetic stabilizers and TTR gene silencing: A new era in therapy for familial amyloidotic polyneuropathies","volume":"17","author":"Adams","year":"2016","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1208760","article-title":"Safety and efficacy of RNAi therapy for transthyretin amyloidosis","volume":"369","author":"Coelho","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cpt.1974","article-title":"Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects","volume":"109","author":"Habtemariam","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/lifemedi\/lnac036","article-title":"NTLA-2001: Opening a new era for gene therapy","volume":"2","author":"Cui","year":"2022","journal-title":"Life Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.amjcard.2022.10.014","article-title":"Overview of Current and Emerging Therapies for Amyloid Transthyretin Cardiomyopathy","volume":"185","author":"Maurer","year":"2022","journal-title":"Am. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","article-title":"The impact of natural products upon modern drug discovery","volume":"12","author":"Ganesan","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: New estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0076-6879(99)09019-9","article-title":"Analysis of protein aggregation kinetics","volume":"309","author":"Ferrone","year":"1999","journal-title":"Meth. Enzymol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13506129.2014.997872","article-title":"Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis","volume":"22","author":"Sekijima","year":"2015","journal-title":"Amyloid"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40120-016-0040-x","article-title":"Mechanism of action and clinical application of tafamidis in hereditary transthyretin amyloidosis","volume":"5","author":"Coelho","year":"2016","journal-title":"Neurol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1073\/pnas.1300761110","article-title":"AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin","volume":"110","author":"Penchala","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/febs.15339","article-title":"Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis","volume":"288","author":"Pinheiro","year":"2021","journal-title":"FEBS J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.febslet.2009.10.062","article-title":"Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity","volume":"583","author":"Ferreira","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1021\/bi1004409","article-title":"The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate- transthyretin complex reveals a novel binding site distinct from the thyroxine binding site","volume":"49","author":"Miyata","year":"2010","journal-title":"Biochemistry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature \u03b1-synuclein and amyloid-\u03b2 fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.febslet.2011.06.030","article-title":"Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation","volume":"585","author":"Ferreira","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"Schmidt","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Balupuri, A., Choi, K.E., and Kang, N.S. (2020). Aggregation Mechanism of Alzheimer\u2019s Amyloid \u03b2-Peptide Mediated by \u03b1-Strand\/\u03b1-Sheet Structure. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031094"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Gonzalez-Duarte, A., and Ulloa-Aguirre, A. (2021). A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222313158"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1021\/acs.biochem.1c00073","article-title":"Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin","volume":"60","author":"Ferguson","year":"2021","journal-title":"Biochemistry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13506120410001682569","article-title":"A rare transthyretin mutation (Asp18Glu) associated with cardiomyopathy","volume":"11","author":"Connors","year":"2004","journal-title":"Amyloid"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/bi027319b","article-title":"D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: A prescription for central nervous system amyloidosis?","volume":"42","author":"Sekijima","year":"2003","journal-title":"Biochemistry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1021\/acs.jcim.2c00447","article-title":"Atomic Mechanisms of Transthyretin Tetramer Dissociation Studied by Molecular Dynamics Simulations","volume":"62","author":"Zhou","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2174\/092986712800269335","article-title":"Nearly 200 X-ray crystal structures of transthyretin: What do they tell us about this protein and the design of drugs for TTR amyloidoses?","volume":"19","author":"Palaninathan","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: Multiple ligand\u2013protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1021\/ja507002p","article-title":"Fibril elongation by A\u03b2(17-42): Kinetic network analysis of hybrid-resolution molecular dynamics simulations","volume":"136","author":"Han","year":"2014","journal-title":"J. Am Chem. Soc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1021\/acs.jpclett.5b00330","article-title":"Shedding Light on the Dock-Lock Mechanism in Amyloid Fibril Growth Using Markov State Models","volume":"6","author":"Schor","year":"2015","journal-title":"J. Phys. Chem. Lett."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1021\/acschemneuro.8b00732","article-title":"Disclosing the template-induced misfolding mechanism of Tau protein by studying the dissociation process of boundary chain from the formed Tau fibril based on the steered molecular dynamics simulation","volume":"10","author":"Liu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"624302","DOI":"10.3389\/fmolb.2021.624302","article-title":"Insight into Seeded Tau Fibril Growth From Molecular Dynamics Simulation of the Alzheimer\u2019s Disease Protofibril Core","volume":"8","author":"Leonard","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1021\/jp312573y","article-title":"Molecular mechanism of the inhibition of EGCG on the Alzheimer A\u03b21\u201342 dimer","volume":"117","author":"Zhang","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington\u2019s disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joim.12585","article-title":"One mutation, two distinct disease variants: Unravelling the impact of transthyretin amyloid fibril composition","volume":"281","author":"Suhr","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/acs.biochem.2c00390","article-title":"Toxic Misfolded Transthyretin Oligomers with Different Molecular Conformations Formed through Distinct Oligomerization Pathways","volume":"61","author":"Dasari","year":"2022","journal-title":"Biochemistry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1039\/D1CP01913A","article-title":"Molecular mechanisms of resveratrol and EGCG in the inhibition of A\u03b2 42 aggregation and disruption of A\u03b2 42 protofibril: Similarities and differences","volume":"23","author":"Li","year":"2021","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/acschemneuro.0c00277","article-title":"Green tea extracts EGCG and EGC display distinct mechanisms in disrupting A\u03b242 protofibril","volume":"11","author":"Zhan","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/acs.biochem.8b00642","article-title":"NMR measurements reveal the structural basis of transthyretin destabilization by pathogenic mutations","volume":"57","author":"Leach","year":"2018","journal-title":"Biochemistry"},{"key":"ref_61","first-page":"6319","article-title":"Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: An observational study","volume":"9","author":"Fabian","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/13506129.2012.668502","article-title":"Natural polyphenols as modulators of TTR amyloidogenesis: In vitro and in vivo evidences towards therapy","volume":"19","author":"Ferreira","year":"2012","journal-title":"Amyloid"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wang, Q., Guo, J., Jiao, P., Liu, H., and Yao, X. (2014). Exploring the Influence of EGCG on the \u03b2-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP1\u201337) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094796"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: The RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and Testing of a General AMBER Force Field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_66","first-page":"37","article-title":"Molecular dynamics simulations: Advances and applications","volume":"8","author":"Hospital","year":"2015","journal-title":"Adv. Appl. Bioinform. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theory Comput."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1021\/ja039788m","article-title":"Proton binding to proteins: pK(a) calculations with explicit and implicit solvent models","volume":"126","author":"Simonson","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1021\/bi00230a009","article-title":"Molecular dynamics simulations of the unfolding of an.alpha.-helical analog of ribonuclease A S-peptide in water","volume":"30","author":"Jorgensen","year":"1991","journal-title":"Biochemistry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"134101","DOI":"10.1063\/1.2013227","article-title":"A configurational temperature Nos\u00e9-Hoover thermostat","volume":"123","author":"Braga","year":"2005","journal-title":"J. Chem. Phys."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0167-7977(86)90022-5","article-title":"Molecular dynamics simulation of rigid molecules","volume":"4","author":"Ciccotti","year":"1986","journal-title":"Comput. Phys. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: An Efficient Program for End-State Free Energy Calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y","article-title":"Reduced surface: An efficient way to compute molecular surfaces","volume":"38","author":"Sanner","year":"1996","journal-title":"Biopolymers"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:51:41Z","timestamp":1760129501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":78,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241814146"],"URL":"https:\/\/doi.org\/10.3390\/ijms241814146","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]}}}